Matthew Phillip Sinnreich - President and Acting CEO, Director at Zeo ScientifiX, Inc.

Issuer-level insider activity

Role: President and Acting CEO, Director
Issuer ticker: ZEOX on OTC
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Matthew Phillip Sinnreich since 14 Aug 2025

Reported holdings for Matthew Phillip Sinnreich in Zeo ScientifiX, Inc.

Form 4 holding President and Acting CEO, Director

Organicell Regenerative Medicine, Inc.

Security class: Common Stock, $0.001 par value
Shares / value: 0
Estimated value
Report date: 31 Oct 2022
Price: $1.32
Ownership: Indirect

Transaction history for Matthew Phillip Sinnreich in Zeo ScientifiX, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .